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Abstract
Background: The PTSD Checklist-civilian (PCL-C) is one of the most commonly used self-report measures of PTSD
symptoms, however, little is known about its validity when used in pregnancy. This study aims to evaluate the
reliability and validity of the PCL-C as a screen for detecting PTSD symptoms among pregnant women.
Methods: A total of 3372 pregnant women who attended their first prenatal care visit in Lima, Peru participated in
the study. We assessed the reliability of the PCL-C items using Cronbach’s alpha. Criterion validity and performance
characteristics of PCL-C were assessed against an independent, blinded Clinician-Administered PTSD Scale (CAPS)
interview using measures of sensitivity, specificity and receiver operating characteristics (ROC) curves. We tested
construct validity using exploratory and confirmatory factor analytic approaches.
Results: The reliability of the PCL-C was excellent (Cronbach’s alpha =0.90). ROC analysis showed that a cut-off
score of 26 offered optimal discriminatory power, with a sensitivity of 0.86 (95% CI: 0.78–0.92) and a specificity of 0.
63 (95% CI: 0.62–0.65). The area under the ROC curve was 0.75 (95% CI: 0.71–0.78). A three-factor solution was
extracted using exploratory factor analysis and was further complemented with three other models using
confirmatory factor analysis (CFA). In a CFA, a three-factor model based on DSM-IV symptom structure had
reasonable fit statistics with comparative fit index of 0.86 and root mean square error of approximation of 0.09.
Conclusion: The Spanish-language version of the PCL-C may be used as a screening tool for pregnant women. The
PCL-C has good reliability, criterion validity and factorial validity. The optimal cut-off score obtained by maximizing
the sensitivity and specificity should be considered cautiously; women who screened positive may require further
investigation to confirm PTSD diagnosis.
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Background
Posttraumatic Stress Disorder (PTSD) is a common and
debilitating trauma and stressor-related disorder that
occurs following exposure to life events involving real or
threatened death, severe injury or sexual assault [1].
PTSD is characterized by four symptom clusters: re-
experiencing, avoidance of stimuli associated with the
event, negative alterations in cognition and mood, and
physiological hyperarousal and reactivity [1]. Changes to
the criteria for PTSD have been introduced in the fifth
Diagnostic and Statistical Manual of Mental Disorder
(DSM-5) definition including moving PTSD from the
anxiety disorders category to a new class of trauma- and
stressor-related disorders. In addition, the three symp-
tom clusters in the fourth edition of the DSM (DSM-IV)
[2] were expanded into four by splitting the avoidance
and numbing cluster into an avoidance cluster and nega-
tive alterations in cognitions and mood cluster. In the
United States, the lifetime prevalence of PTSD in the
general population ranges from 6 to 8% and ranges from
1 to 9% worldwide [3–6].
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Women have a greater risk of PTSD as compared with
their male counterparts [3, 4, 7–9]. Of note, women are
at particularly elevated risk for PTSD during their repro-
ductive years, especially during pregnancy and postpar-
tum, with PTSD symptoms likely to reach their peak
severity closer to delivery [10]. The point prevalence of
PTSD among pregnant women has been reported to
range from 2.3 to 16% [7, 11–13]. This wide variation
has been attributed to differences in the level and
amount of trauma exposure, proximity to the trauma,
length of time since trauma, differences in assessment
tools used and population characteristics [7, 11–13].
PTSD in pregnancy is associated with perinatal compli-
cations including ectopic pregnancy [14], spontaneous
abortion [14], hyperemesis gravidarum [14], preterm
labor [15], preterm delivery [16, 17], low birth weight
[16] and excessive fetal growth [14]. PTSD during
pregnancy may also lead to other psychiatric disorders,
including first-onset major depression, anxiety, bipolar
disorder and alcohol abuse or dependence [8]. However,
diagnosis and treatment of PTSD among pregnant and
postpartum women remains low, especially in low- and
middle-income countries. This is due, in part, to the lack
of skilled mental health professionals, stigma associated
with mental disorders, and lack of cross-culturally vali-
dated screening and diagnostic instruments [18–22].
The Posttraumatic Stress Disorders Checklist (PCL),
one of the most commonly used self-reported question-
naires for PTSD detection [23], consists of 17 items
which correspond to the symptoms of PTSD in the
DSM-IV [24]. The Civilian version of PCL (PCL-C),
designed for general traumatic experience [25], has been
shown to be a valid and reliable tool for screening and
managing PTSD symptoms in various clinical and
population-based settings according to DSM-IV criteria
[26, 27]. Recently, the PCL was revised to PCL-5 reflecting
DSM-5 changes to the PTSD criteria. Overall, the symp-
toms of PTSD have been reported to be comparable
between DSM-5 and DSM-IV [28].
Despite its increased utility, to date, no study has
evaluated the utility of PCL-C in pregnancy. Moreover,
only four investigative teams have published studies doc-
umenting the psychometric properties of PCL-C when
used in South American populations [29–32]. Notably,
none of these studies were conducted in Peru. Peru, a
middle-income and post-conflict country, is one of the
countries with the highest prevalence of violence against
women [33]. A recent study conducted in Peru found
that one in four women reported being physically or
sexually abused during pregnancy (21.4%), including in
extreme forms of violence such as rape [34]. Further-
more, Barrios et al. recently noted that 24% of pregnant
women reported being raped or being victims of
attempted rape before the age of 15 years [35].
Given this background of a high prevalence of interper-
sonal violence, particularly sexual violence experienced by
reproductive aged and pregnant women, we conducted
the present study to evaluate the reliability and validity
(specifically the construct and criterion validity) of the
Spanish-language version of the PCL-C against a
Clinician-Administered PTSD Scale (CAPS) reference/
gold standard among pregnant Peruvian women [36].
Additionally, we assessed the optimal cut-off points for
discrimination between participants with and without
PTSD using the PCL-C instrument. Evaluating the factor
structure of a screening questionnaire when applied in
new context or cultural background has been one of the
widely-used methods of assessing psychometric proper-
ties. Hence, we also evaluated the factor structure of the
PCL-C questionnaire using exploratory and confirmatory
factor analytic approaches.
Methods
Study participants
This cross-sectional study was a part of the Pregnancy
Outcomes, Maternal and Infant Study (PrOMIS) Cohort,
which is an ongoing prospective cohort study. The study
population was drawn from pregnant women receiving
prenatal care at the Instituto Nacional Materno Perinatal
(INMP) in Lima, Peru between February 2012 and
March 2014. Under the aegis of the Peruvian Ministry of
Health, the INMP is the primary referral health estab-
lishment for maternal and perinatal care. Pregnant
women between the ages of 18 and 49 years, with a
gestational age of ≤16 weeks, and who spoke and under-
stood Spanish were eligible for inclusion.
Study procedures
We used a two-stage study design where participants
were first interviewed in-person by trained social
workers using the PCL-C. Within 15 days of the ini-
tial interview, randomly selected participants were in-
vited to take part in a diagnostic interview conducted
by licensed psychologists who were blinded to the
PCL-C questionnaire outcome using the CAPS. Dur-
ing the PCL-C interview, information pertaining to
maternal sociodemographic, behavioral characteristics
as well as medical and reproductive histories was
ascertained. The questionnaire, originally written in
English, was translated into Spanish by a team of
native Spanish speakers (including co-author, SES).
To ensure proper expression and conceptualization of
terminologies in local contexts, the translated version
was back-translated and modified until the back-
translated version was comparable with the original
English version.
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Screening instrument
The PCL-C assesses posttraumatic stress disorder using
17 items designed according to the DSM– IV criteria.
For each item, the participant is asked to indicate how
much they have been bothered by each symptom over
the past month on a 5-point Likert scale categorized as
1 (not at all), 2 (a little bit), 3 (moderately), 4 (quite a
bit) and 5 (extremely) with regards to stressful life ex-
periences. The PCL-C total score (i.e., sum of scores for
the 17 items) ranges from 17 to 85. The PCL-C has
been shown to have excellent internal consistency, test-
retest reliability and convergent validity among both
clinical and nonclinical populations [25–27, 37]. The
Spanish-language version of the PCL-C has also been
shown to have psychometric properties roughly similar
to those reported for the English-language version [38].
An interviewer administered PCL-C has been used in
prior studies (Additional file 1).
Diagnostic instrument-interview
The CAPS, the diagnostic criterion gold standard instru-
ment selected for our study, was used to determine the
presence of a PTSD diagnosis during the past 12 months.
The CAPS is a structured interview for ascertainment of
a PTSD diagnosis using DSM-IV criteria, including
criterion A (exposure), criteria B – D (core symptoms
clusters), criterion E (chronology), criterion F (functional
impairment), and the associated symptoms of guilt and
dissociation [36, 39]. The CAPS has excellent reliability,
validity, diagnostic utility, and sensitivity to clinical
change, and has been widely used as a standard criterion
measure of PTSD [40].
Two-stage sample selection
Of the 3775 eligible participants, 3372 (89.3%) com-
pleted a structured in-person interview. Due to miss-
ing information on the PCL-C, 83 participants were
excluded, leaving 3289 participants with completed
PCL-C information in this analysis. Due to cost and
time constraints, a subset of participants (N = 641,
19.5%) was randomly selected to complete a diagnos-
tic interview within 15 days of the initial structured
interview. Of the 641 women, eight participants
missing information on PCL-C were excluded, and
633 participants with completed PCL-C and CAPS
interview information remained in the diagnostic
accuracy analysis.
Statistical analysis
Reliability
We assessed the reliability of PCL-C using several agree-
ment and consistency indices. Specifically, the Cronbach’s
alpha (using the PCL-C total score) and item-total
correlations were computed to assess the internal
consistency and homogeneity of PCL-C items.
Criterion validity
The criterion validity for the PCL-C was assessed based
on the CAPS diagnosis of PTSD. We computed the
following operating characteristics: sensitivity, specificity,
positive likelihood ratio, negative likelihood ratio, posi-
tive predictive values, and negative predictive values. To
identify the best PCL-C cut-off score to use for PTSD
screening of Spanish-speaking Peruvian pregnant women
in early pregnancy, we completed receiver operating
characteristic (ROC) curve analyses to identify optimal
balance of sensitivity and specificity, area under the
ROC curve (AUC) and we estimated the associated non-
parametric 95% CI for the AUC. Additionally, we calcu-
lated the Youden Index, a metric used for identifying an
optimum cut-off score for screening test. Briefly, the
Youden index is a function of sensitivity and specificity
calculated as the (sensitivity + specificity - 1). The range
of the index is from 0 to 1 [41] with the higher values
designating an optimum cut-off.
As noted above, because of cost and time con-
straints, we employed a two-stage design where a sub-
set of participants screened with the PCL-C was
assessed using the clinician administered CAPS. Since
a subset of women screened with the PCL-C was se-
lected for CAPS diagnostic interviews, it is possible to
have verification bias. Given the likelihood of referral
or verification bias [42], we implemented an analytical
strategy that corrects for bias introduced as a result of
our study design. Specifically, we evaluated the Begg
and Greenes adjusted estimates of psychometric
properties. Estimates generated from this analysis are
corrected for verification bias using a Bayes Theorem
approach [43] which applies a missing at random
(MAR) assumption. Because it has been shown that
the asymptotic confidence intervals might be unreli-
able in validation studies, we calculated bootstrapped
confidence intervals to render estimated confidence
intervals closer to their expected values [44].
Construct validity
Using exploratory factor analysis (EFA) and confirma-
tory factor analysis (CFA), we explored the factor struc-
ture of PCL-C. Prior to performing factor analysis, we
assessed the suitability of the data for performing factor
analysis. This analysis showed that it is appropriate to
proceed with factor analysis (Bartlett’s test of sphericity
(p < 0.001), and the Kaiser-Meyer-Olkin measure of
sampling adequacy = 0.93). We then used the scree plot,
presenting the eigenvalues associated with each factor, to
identify the number of meaningful factors. Factors with
relatively large eigenvalues (greater than one) were
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assumed to be meaningful and were retained for rotation.
Factors with small eigenvalues were not retained [45].
Factor loadings >0.5 were used in the factor designa-
tion. To complement the EFA, we conducted CFA to
evaluate the fit of three-factor and four-factor models
identified in the literature corresponding to DSM-IV
and DSM-5. The chi-square statistics, standardized
root mean square residual (SRMR), the comparative
fit index (CFI) and the root mean square error of
approximation (RMSEA) were calculated. The follow-
ing criteria are recommended to provide evidence for
reasonably good fit [46]: 1) SRMR close to 0.08 or
below; 2) CFI close to 0.95 or above; and 3) RMSEA
close to 0.06 or below.
Results
Participant characteristics
A summary of selected sociodemographic and repro-
ductive characteristics of study participants is presented
in Table 1. A total of 3289 participants between the ages
of 18 and 49 years (mean age = 28.2 years; standard
deviation =6.3 years) participated in the study. The aver-
age gestational age at interview was 9.3 weeks (standard
deviation =4.3 weeks). The majority of participants were
Table 1 Sociodemographic and reproductive characteristics of the study population
Characteristic All Diagnostic interview PCL-C screening only P valuea
(N = 3289) (N = 633) (N = 2656)
n % n % n %
Age (yr)b 28.2 ± 6.3 28.2 ± 6.1 28.2 ± 6.3 0.99
Age (yr)
18–20 169 5.1 29 4.6 140 5.3 0.68
20–29 1836 55.8 367 58.0 1469 55.3
30–34 692 21.0 128 20.2 564 21.2
≥ 35 591 18.0 109 17.2 482 18.1
Education (yr)
≤ 6 143 4.3 25 3.9 118 4.44 0.75
7–12 1787 54.3 339 53.6 1448 54.5
> 12 1349 41.0 267 42.2 1082 40.7
Mestizo 2475 75.3 481 76.0 1994 75.1 0.65
Married/living with a partner 2658 80.8 518 81.8 2140 80.6 0.50
Employed 1515 46.1 307 48.5 1208 45.5 0.19
Access to basic food
Hard 1630 49.6 302 47.7 1328 50.0 0.31
Not very hard 1657 50.4 331 52.3 1326 49.9
Difficulty in paying for medical care
Hard 1740 52.9 316 49.9 1424 53.6 0.11
Not very hard 1541 46.9 315 49.8 1226 46.2
Nulliparous 1609 48.9 333 52.6 1276 48.0 0.04
Unplanned pregnancy 1892 57.5 352 55.6 1540 58.0 0.28
Gestational age at interview (wk)b 9.3 ± 4.3 9.6 ± 3.4 9.2 ± 4.7 0.02
Any lifetime sexual or physical abuse by intimate partnerc
No 2096 63.7 442 69.8 1654 62.3 <0.001
Yes 1181 35.9 188 29.7 993 37.4
Any childhood physical or sexual abused
No 937 28.5 190 30.0 747 28.1 0.38
Yes 2308 70.2 436 68.9 1872 70.5
Due to missing data, percentages may not add up to 100%
aFor continuous variables, p value was calculated using Student’s t test; for categorical variables, p value was calculated using either Chi-square test or Fisher’s exact test
bmean ± standard deviation
cIntimate partner abuse assessed using the Demographic Health Survey Questionnaires and Modules: Domestic Violence Module [48] and the WHO Multi-Country
Study on Violence Against Women [68]
dExperiences of childhood physical and sexual abuse assessed using Childhood Physical and Sexual Abuse Questionnaire [47]
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Mestizos (75.3%), married or living with a partner
(80.8%), and had at least 7 years of education (95.3%).
About half of the participants were unemployed (53.9%),
reported difficulty paying for the very basics (49.6%), nul-
liparous (48.9%) and reported the index pregnancy was un-
planned (57.5%). The vast majority of participants
reported experiencing physical or sexual abuse as a
child [47] (70.2%), and one-third of participants re-
ported experiencing lifetime physical or sexual intim-
ate partner violence [48] (35.9%).
Twenty participants fulfilled the DSM-IV criteria for
PTSD diagnosis based on CAPS interview (3% of the
population). Overall PCL-C scores were higher among
individuals with PTSD (median = 29; interquartile
range: 27–35.25) compared to the non-PTSD individ-
uals (median = 23; interquartile range: 19–28,
p < 0.001) (Additional file 2).
Reliability
The internal consistency of the PCL-C gave a Cron-
bach’s alpha of 0.90. The correlations between the 17
items of the PCL-C and the total scores ranged from
0.41 to 0.77 (all p-values <0.0001), indicating good
relationship between each item and all the other
items on the scale (Table 2).
Validity
Criterion validity
Using the CAPS as the criterion gold standard, the opti-
mal cut-off of PCL-C for maximizing the sensitivity
without loss of specificity was a score of ≥26 (Table 3).
At the optimal cut-off score, the sensitivity and specifi-
city of PCL-C for detecting PTSD in this population
were 0.86 (95% CI: 0.78–0.92) and 0.63 (95% CI: 0.62–
0.65), respectively. The positive likelihood ratio was 2.35
(95% CI: 2.16–2.57) with negative likelihood ratio of 0.22
(95% CI: 0.14–0.35). This suggested that women with
PTSD were 2.35 times more likely than women without
PTSD to have a PCL-C score equal or greater than 26,
and were 0.22 times as likely to have a PCL-C score less
than 26. The positive predicted value was 0.08 (95% CI:
0.06–0.09) and the negative predicted value was 0.99
(95% CI: 0.99–1.00). The area under the ROC curve for
detecting PTSD at a PCL-C score of 26 or higher was
0.75 (95% CI: 0.71–0.78) (P < 0.01) (Additional file 3).
The results largely remained similar when stratified by
experiences of lifetime sexual or physical abuse by an
intimate partner (Additional files 4 and 5).
Construct validity
The results obtained from EFA indicated a three-factor
solution (Table 4) with eigenvalues greater than 1.0, which
accounted for 55% of the common variance. The factor
loadings of all 17 items were greater than 0.5. Factor 1
consisted primarily of re-experiencing and avoidance symp-
toms, factor 2 consisted of dysphoria symptoms, and factor
3 was primarily comprised of hyperarousal symptoms.
Additional file 6 details the item mapping for the
model from EFA analysis (Model 1), models identified
from previous studies (Model 2–4) that underwent
CFA. In addition to our EFA, we carried out a CFA
to examine the construct validity and to test whether
the factorial structure of PCL-C has a three-factor model.
The three-factor model (Model 2) based on DSM-IV
symptom structure had reasonable fit statistics with com-
parative fit index of 0.86 and RMSEA of 0.09). Model 3, a
four-factor mode, corresponding to DSM-5, had better-fit
statistics with CFI of 0.94. The RMSEA (0.06) and SRMR
(0.04) values were acceptable indicating reasonable error
of approximation (Table 5). Detailed path diagram, factor
loadings as well as item variances are shown in Fig. 1
corresponding to DSM-5 factors of re-experiencing,
avoidance, numbing and hyperarousal.
Discussion
To our knowledge, this is the first validation study of the
Spanish-language version of the PCL-C questionnaire as
a screening tool for PTSD in pregnancy. When com-
pared with a criterion gold standard (CAPS), the PCL-C
has a good validity (sensitivity (86%) and specificity
Table 2 Item level values and item-total correlation of PCL-C
Item Corrected item-total
correlation
Alpha if Item
deleted
1. Memories/thoughts/images 0.66 0.90
2. Repeated, disturbing dreams 0.62 0.90
3. Acting/feeling as if happening
again
0.67 0.90
4. Feeling upset at reminders 0.77 0.89
5. Physical reactions at reminders 0.67 0.90
6. Avoid thinking/talking/feelings 0.72 0.89
7. Avoid activities/situations 0.73 0.89
8. Trouble remember details 0.59 0.90
9. Loss of interest in activities 0.60 0.90
10. Feeling distant or cut off from
others
0.63 0.90
11. Feeling emotionally numb 0.56 0.90
12. Feeling as if future cut short 0.61 0.90
13. Trouble sleeping 0.51 0.90
14. Irritability/angry outbursts 0.66 0.90
15. Difficulty concentrating 0.61 0.90
16. Super alert or watchful 0.41 0.90
17. Jumpy or easily started 0.63 0.90
Sum score N/A 0.90a
aOverall Cronbach’s alpha based on sum score; PCL-C Posttraumatic Stress
Disorders Checklist Civilian Version
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(63%) for detecting PTSD symptoms among Peruvian
pregnant women. Our ROC analysis and Youden index
showed that a threshold of 26 on the PCL-C was the most
appropriate cut-off and offered the optimal discriminatory
power in detecting PTSD in our study population. In
addition, our study provided strong evidence for the con-
struct validity of the PCL-C with a four-factor structure
consisting of re-experiencing, avoidance, numbing and
hyperarousal. Our findings are consistent with reports
from prior studies [49–53].
In our study, the sensitivity and specificity of PCL-C
at the optimal cut-off score of 26 or greater was 0.86
(95% CI: 0.78–0.92) and 0.63 (95% CI: 0.62–0.65),
respectively. An excellent negative predicted value of
0.99 was obtained at the optimal cut-off point of 26.
The positive predicted value (PPV) was relatively poor
(0.08), partly due to the low prevalence (3%) of PTSD
in the population. The PPV depends on sensitivity, spe-
cificity, and prevalence of PTSD among study partici-
pants. In our population, the relatively low 12-month
prevalence of PTSD (3%) based on the CAPS diagnosis
likely accounts for the low PPV in our study. In the
original validation study of PCL-C conducted among
motor vehicle accident and sexual assault victims
Blanchard et al. found the optimal cut-off score of 44
resulted in a sensitivity of 94% and specificity of 86%
when compared with CAPS reference standard [54].
Subsequently, other investigators have evaluated the
validity of PCL-C reporting optimum cut-off scores
ranging from 28 to 60 (Additional file 1). McDonald
and Calhoun have reported similar observations in their
review of 12 studies that used PCL-C [55]. The cut-off
scores in our study were similar with some studies. For
instance, Walker et al. in their study of women attend-
ing a health maintenance organization (HMO) in Se-
attle found that the optimum PCL-C cut-off score was
30 with a sensitivity of 82% and specificity of 76% [56].
Andrykowski et al. in their study of women with breast
Table 3 Sensitivity and specificity for PTSD diagnosis across various cut-off scores of PCL-C
Cut-off
Score
Sensitivity
(95% CI)
Specificity
(95% CI)
Youden
index
+PV (95% CI) -PV (95% CI) +LR (95% CI) -LR (95% CI) PR
20 0.95 (0.90, 0.99) 0.23 (0.22, 0.25) 0.18 0.04 (0.03, 0.05) 0.99 (0.98, 1.00) 1.24 (1.19, 1.30) 0.20 (0.08, 0.47) 0.77
22 0.91 (0.84, 0.96) 0.41 (0.39, 0.43) 0.32 0.05 (0.04, 0.06) 0.99 (0.99, 1.00) 1.53 (1.44, 1.64) 0.22 (0.12, 0.41) 0.60
24 0.86 (0.78, 0.92) 0.54 (0.52, 0.55) 0.40 0.06 (0.05, 0.07) 0.99 (0.99, 1.00) 1.86 (1.70, 2.02) 0.26 (0.16, 0.42) 0.48
26 0.86 (0.78, 0.92) 0.63 (0.62, 0.65) 0.49 0.08 (0.06, 0.09) 0.99 (0.99, 1.00) 2.35 (2.16, 2.57) 0.22 (0.14, 0.35) 0.38
28 0.68 (0.58, 0.77) 0.70 (0.69, 0.72) 0.38 0.07 (0.06, 0.09) 0.99 (0.98, 0.99) 2.29 (1.99, 2.64) 0.46 (0.35, 0.60) 0.31
30 0.49 (0.39, 0.59) 0.76 (0.74, 0.77) 0.25 0.06 (0.05, 0.08) 0.98 (0.97, 0.98) 2.01 (1.64, 2.46) 0.67 (0.56, 0.81) 0.25
35 0.40 (0.31, 0.50) 0.87 (0.86, 0.88) 0.27 0.09 (0.07, 0.12) 0.98 (0.97, 0.98) 3.01 (2.35, 3.84) 0.69 (0.59, 0.81) 0.14
40 0.26 (0.18, 0.36) 0.91 (0.90, 0.92) 0.17 0.10 (0.06, 0.13) 0.97 (0.97, 0.98) 3.05 (2.19, 4.25) 0.81 (0.72, 0.90) 0.09
45 0.13 (0.07, 0.21) 0.95 (0.94, 0.95) 0.08 0.08 (0.04, 0.12) 0.97 (0.96, 0.98) 2.46 (1.48, 4.09) 0.92 (0.85, 0.99) 0.06
Abbreviations: +PV positive predicted value, −PV negative predicted value, +LR positive likelihood ratio, −LR negative likelihood ratio, PR prevalence; Bold text
indicates the optimum cut-off
Table 4 Exploratory factor analysis of PCL-C
Item Factor 1 Factor 2 Factor 3
1. Memories/thoughts/images 0.68 0.07 0.01
2. Repeated, disturbing dreams 0.70 0.11 −0.15
3. Acting/feeling as if happening again 0.74 0.10 −0.11
4. Feeling upset at reminders 0.74 0.04 0.16
5. Physical reactions at reminders 0.65 0.07 0.07
6. Avoid thinking/talking/feelings 0.74 −0.11 0.28
7. Avoid activities/situations 0.75 −0.08 0.25
8. Trouble remember details 0.59 0.19 −0.14
9. Loss of interest in activities 0.15 0.60 -0.05
10. Feeling distant or cut off from others 0.10 0.69 -0.03
11. Feeling emotionally numb 0.10 0.70 -0.15
12. Feeling as if future cut short 0.13 0.65 -0.04
13. Trouble sleeping −0.11 0.54 0.27
14. Irritability/angry outbursts −0.04 0.49 0.53
15. Difficulty concentrating 0.00 0.60 0.20
16. Super alert or watchful 0.07 −0.17 0.78
17. Jumpy or easily started −0.05 0.44 0.55
Factor loadings >0.5 are in bold
Table 5 Fit indices for confirmatory factor analysis models
Model Chi-sq. (df) SRMR RMSEA CFI
1 2344.22 (116) 0.04 0.08 0.90
2 3379.95 (116) 0.07 0.09 0.86
3 1404.67 (113) 0.04 0.06 0.94
4 1830.05 (113) 0.05 0.07 0.93
Abbreviations: Chi-sq. (df) chi-square statistic (degree of freedom), SRMR
standardized root mean square residual, RMSEA root mean square error of
approximation, CFI comparative fit index; Bold indicates the best fitting model
Model 1: Factor 1—1,2,3,4,5,6,7,8; Factor 9,10,11,12,13,15; Factor 3—14,16,17
Model 2: Factor 1—1,2,3,4,5,6,7,8; Factor 2—9,10,11,12,13,15; and Factor 3—14,17
Model 3: Factor 1—1,2,3,4,5; Factor 2—6,7; Factor 3—8,9,10,11,12; and
Factor 4—13,14,15,16,17
Model 4: Factor 1—1,2,3,4,5; Factor 2—6,7; Factor 3—8,9,10,11,12,13,14,15 and
Factor 4—16,17
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cancer found the optimum PCL-C cut-off score to be
30 yielding a sensitivity of 100% and specificity of 83%
[57]. The wide variation in cut-off scores between stud-
ies may be attributable to differences in prevalence of
PTSD, demographics, disease severity, comorbidity, and
other characteristics of populations. We do not have a
clear explanation for the low prevalence of PTSD by
CAPS in our study. One potential reason is that high
levels of history of childhood abuse, intimate partner
violence, anxiety about pregnancy, delivery and health
of the fetus may have desensitized them to PTSD symp-
toms or make them feel less comfortable discussing the
PTSD symptoms in a face-to-face interview with the
psychologists. Future studies are needed to provide
further insights into this issue. Moreover, our study was
conducted in early pregnancy. It is possible that vulner-
ability to PTSD symptoms might increase throughout
pregnancy due to physiological and neuroendocrine
changes associated with pregnancy, fear of childbirth &
pain, and ongoing exposure to violence as the preg-
nancy progresses [13].
Using exploratory and confirmatory factor analytic
approaches, we confirmed the multi-dimensionality of
the PCL-C, which is consistent with the majority of
studies conducted in primary care settings [52, 53, 58]
or general population-based research setting [59]. [60]
The four-factor model proposed by King et al. [61] with
four inter-correlated factors (re-experiencing, avoidance,
numbing and hyperarousal) provided the best fit. Although
the PCL-C items map directly onto criteria B (re-experien-
cing), C (avoidance/numbing) and D (hyperarousal) of
DSM-IV PTSD diagnosis, the three-factor model did not
provide the best fit in the present study. These findings are
consistent with results from previous studies that found a
four-factor model of PCL-C using either exploratory or
confirmatory factor analysis [52, 58, 60–63].
Of note, several investigators have questioned the
three-factor model of PCL-C conceptualizing DSM-IV
criteria as little empirical data supports this hypothesis
[23]. The current definition PTSD according to DSM-5
also suggests that avoidance and numbing may be two
conceptually independent factors and should be split
Fig. 1 Path diagram of the selected confirmatory factor analysis model
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into avoidance cluster and negative alterations in cogni-
tion and mood cluster [64, 65]. In sum, the results of
our study and those of others [60, 66, 67] indicate that a
four-factor model of PCL-C may best represent the
latent structure of PTSD [26].
Overall, the PCL-C demonstrated good item-total
correlations. Compared to other items, Item 16 (Be-
ing “super alert” or watchful on guard) had the low-
est item-total correlation (0.41) and loaded only
moderately on the factor. Other investigators have
reported similar lower item-total correlation and
lower loading of Item 16 [32, 52, 66, 67]. It is not
clear whether the low loading was due to wording prop-
erty, a subtype of PTSD or potential confounding associ-
ated with pregnancy and life condition. Future exploration
is required to empirically test the subtype hypothesis and
validate the PCL-C, especially for the Spanish-language
version across regions and populations in other Spanish-
speaking countries.
Our study has several strengths including the use of a
diagnostic gold standard to assess validity, a relatively
large sample size, and execution of a rigorous analytic
plan. Furthermore, our study expands the literature by
including assessment of the Spanish-language version of
the PCL-C among pregnant women. Despite these
strengths, some limitations much be considered when
interpreting our findings. First, four psychologists
conducted the diagnostic interviews, and their inter-
rater reliability was not calculated. Second, as anxiety
levels might vary during the course of pregnancy, lon-
gitudinal studies are warranted to help understand
how PTSD symptom severity changes across preg-
nancy trimesters. Finally, test-retest reliability was not
calculated in our study.
Conclusion
In conclusion, our results suggest that the Spanish-
language version of the PCL-C may be used as a screening
tool for pregnant women. The PCL-C has good reli-
ability, factorial validity, and concurrent validity. In
practical use, the optimal cut-off score in this study
(PCL-C score ≥ 26) obtained by maximizing the over-
all rate of correct classification should be considered
cautiously; woman who screened positive may require
further investigation to confirm PTSD diagnosis. The
patient’s pre-test probability of PTSD as well as the
different costs of misclassification errors need to be
taken into account for choosing an optimal cut-off
score that minimize the average loss in classifying
patients [42]. Further studies that evaluate the utility
of correct classification would provide more evidence
for determining the optimal cut-off score for pregnant
women.
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